Welcome to the iCAD Investors Page

iCAD, Inc. an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer. The core business delivers innovative cancer detection and radiation therapy  solutions and services that enable clinicians to find and treat cancers earlier and  while enhancing patient care. The comprehensive iCAD technology platforms include advanced hardware and software as well as management services designed to support cancer detection (CAD) and radiation therapy (eBx) treatments.

The company's common stock is listed on the NASDAQ Stock Market under the symbol "ICAD".

LifeSci Advisors

Jeremy Feffer
917-749-1494

jeremy@lifesciadvisors.com

Media Inquiries

ARPR, LLC
Paul Barren
855.300.8209 ext 126
paul@arpr.com

iCAD is committed to corporate sustainability and to making a difference for our environment.

Recent Events and Webcasts

CONNECT

© 2018, iCAD Inc.  All rights reserved.  iCAD, the iCAD logo and PowerLook are a trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.

iCAD, Inc. an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer. The core business delivers innovative cancer detection and radiation therapy  solutions and services that enable clinicians to find and treat cancers earlier and  while enhancing patient care. The comprehensive iCAD technology platforms include advanced hardware and software as well as management services designed to support cancer detection (CAD) and radiation therapy (eBx) treatments.